ID
BIIB icon

Integral Derivatives’s Biogen BIIB Stock Holding History

Integral Derivatives’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.51M Sell
5,500
-5,100
-48% -$1.58M 0.04% 167
2017
Q4 		$3.38M Sell
10,600
-2,200
-17% -$706K 0.07% 195
2017
Q3 		$4.01M Buy
12,800
+1,300
+11% +$385K 0.07% 176
2017
Q2 		$3.12M Sell
11,500
-15,200
-57% -$4.02M 0.06% 200
2017
Q1 		$7.3M Buy
26,700
+3,000
+13% +$848K 0.13% 83
2016
Q4 		$6.72M Sell
23,700
-1,600
-6% -$474K 0.12% 102
2016
Q3 		$7.92M Sell
25,300
-3,300
-12% -$977K 0.17% 80
2016
Q2 		$6.92M Buy
28,600
+7,100
+33% +$1.87M 0.17% 77
2016
Q1 		$5.6M Buy
21,500
+3,600
+20% +$951K 0.18% 80
2015
Q4 		$5.48M Sell
17,900
-22,500
-56% -$6.47M 0.14% 116
2015
Q3 		$11.8M Buy
40,400
+20,700
+105% +$6.84M 0.32% 41
2015
Q2 		$7.96M Buy
19,700
+12,300
+166% +$4.94M 0.22% 83
2015
Q1 		$3.13M Sell
7,400
-26,800
-78% -$10.6M 0.07% 181
2014
Q4 		$11.6M Buy
34,200
+2,900
+9% +$938K 0.2% 74
2014
Q3 		$10.4M Buy
31,300
+3,200
+11% +$1.06M 0.18% 82
2014
Q2 		$8.86M Buy
28,100
+9,900
+54% +$2.98M 0.15% 98
2014
Q1 		$5.57M Buy
18,200
+9,500
+109% +$3.02M 0.11% 165
2013
Q4 		$2.43M Buy
+8,700
New +$2.25M 0.03% 418

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Integral Derivatives's BIIB Position: Q1 2018 in Review

Integral Derivatives opened a new position in Biogen (BIIB) in Q1 2018: 2,095 shares worth $574K. The stake represents 0.01% of the portfolio and ranks #355 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in BIIB as recently as Q1 2017.

Integral Derivatives first reported a position in BIIB in Q3 2014 and has held it in 11 quarters since. The position peaked at $4.72M in Q4 2014. 1,101 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Integral Derivatives held 2,095 shares of Biogen worth $574K as of Q1 2018.
  • Biogen was a new Integral Derivatives position in Q1 2018.
  • Biogen made up 0.01% of Integral Derivatives's portfolio in Q1 2018, its #355 holding.
  • Integral Derivatives first reported a position in Biogen in Q3 2014 and has held it in 11 quarters since.
  • Integral Derivatives's Biogen position peaked at $4.72M in Q4 2014.
  • 1,101 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.